{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:15:50Z","timestamp":1791400550009,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1007\/s10495-005-1877-0","type":"journal-article","created":{"date-parts":[[2005,5,20]],"date-time":"2005-05-20T15:39:48Z","timestamp":1116603588000},"page":"481-491","source":"Crossref","is-referenced-by-count":62,"title":["Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity"],"prefix":"10.1007","volume":"10","author":[{"given":"F.","family":"Habens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Packham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1877_CR1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF. Chen","year":"2004","unstructured":"Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392\u2013401.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1877_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2003.12.003","volume":"29","author":"Y. Yamamoto","year":"2004","unstructured":"Yamamoto Y, Gaynor RB. IkappaB kinases: Key regulators of the NF-kappaB pathway. Trends Biochem Sci2004; 29: 72\u201379.","journal-title":"Trends Biochem Sci"},{"key":"1877_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cbf.1082","volume":"22","author":"S. Ali","year":"2004","unstructured":"Ali S, Mann DA. Signal transduction via the NF-kappaB pathway: A targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 2004; 22: 67\u201379.","journal-title":"Cell Biochem Funct"},{"issue":"9","key":"1877_CR4","first-page":"90","volume":"92","author":"MF. Romano","year":"1998","unstructured":"Romano MF, Lamberti A, Tassone P, et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998; 92:9 90\u201395.","journal-title":"Blood"},{"key":"1877_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-472X(02)01046-9","volume":"31","author":"A. Zaninoni","year":"2003","unstructured":"Zaninoni A, Imperiali FG, Pasquini C, Zanella A, Barcellini W. Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia. Exp Hematol 2003; 31: 185\u2013190.","journal-title":"Exp Hematol"},{"key":"1877_CR6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood-2003-02-0540","volume":"103","author":"C. Kern","year":"2004","unstructured":"Kern C, Cornuel JF, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004; 103: 679\u2013688.","journal-title":"Blood"},{"key":"1877_CR7","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4049\/jimmunol.164.4.2200","volume":"164","author":"RR. Furman","year":"2000","unstructured":"Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 2000; 164: 2200\u20132206.","journal-title":"J Immunol"},{"key":"1877_CR8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","volume":"18","author":"S. Cuni","year":"2004","unstructured":"Cuni S, Perez-Aciego P, Perez-Chacon G, et al. A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391\u20131400.","journal-title":"Leukemia"},{"key":"1877_CR9","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","volume":"194","author":"RE. Davis","year":"2001","unstructured":"Davis RE, Brown KD, Siebenlist U, et al. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861\u20131874.","journal-title":"J Exp Med"},{"key":"1877_CR10","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","volume":"277","author":"T. Hideshima","year":"2002","unstructured":"Hideshima T, Chauhan D, Richardson P, et al. NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem 2002; 277: 16639\u201316647.","journal-title":"J Biol Chem"},{"key":"1877_CR11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","volume":"121","author":"MC. Wright","year":"2001","unstructured":"Wright MC, Issa R, Smart DE, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685\u2013698.","journal-title":"Gastroenterology"},{"key":"1877_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(00)80159-2","volume":"33","author":"A. Lang","year":"2000","unstructured":"Lang A, Schoonhoven R, Tuvia S, et al. Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol 2000; 33: 49\u201358.","journal-title":"J Hepatol"},{"key":"1877_CR13","unstructured":"Oakley F, Meso M, Iredale JP, et al. The IKK inhibitor sulfasalazine stimulates JNK-dependent hepatic stellate cell apoptosis and recovery from rat liver fibrosis. Gastroenterology (In press)."},{"key":"1877_CR14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/009127009803801101","volume":"38","author":"JI. Lee","year":"1998","unstructured":"Lee JI, Burckart GJ. Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 1998; 38: 981\u2013993.","journal-title":". J Clin Pharmacol"},{"key":"1877_CR15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002281-199705000-00003","volume":"9","author":"PG. Conaghan","year":"1997","unstructured":"Conaghan PG, Lehmann T, Brooks P. Disease-modifying antirheumatic drugs. Curr Opin Rheumatol 1997; 9: 183\u2013190.","journal-title":"Curr Opin Rheumatol"},{"key":"1877_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.med.52.1.299","volume":"52","author":"SB. Hanauer","year":"2001","unstructured":"Hanauer SB, Dassopoulos T. Evolving treatment strategies for inflammatory bowel disease. Annu Rev Med 2001; 52: 299\u2013318.","journal-title":"Annu Rev Med"},{"key":"1877_CR17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00541351","volume":"5","author":"M. Farr","year":"1985","unstructured":"Farr M, Brodrck, Bacon PA. Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis. Rheumatol Int 1985; 5: 247\u2013251.","journal-title":"Rheumatol Int"},{"key":"1877_CR18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/cpt1972134539","volume":"13","author":"H. Schroder","year":"1972","unstructured":"Schroder H, Campbell DES. Absorption, metabolism and excretion of salicylazosulfapyridine in man. Clin Pharmacol Therapeutics 1972; 13: 539\u2013551.","journal-title":"Clin Pharmacol Therapeutics"},{"key":"1877_CR19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.14.8.631","volume":"14","author":"KM. Das","year":"1973","unstructured":"Das KM, Eastwood MA, McManus JPA, et al. The metabolism of salicylazosulphapyridine in ulcerative colitis. Gut 1973; 14: 631\u2013641.","journal-title":"Gut"},{"key":"1877_CR20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C. Wahl","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, et al. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163\u20131174.","journal-title":"J Clin Invest"},{"key":"1877_CR21","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","volume":"119","author":"CK. Weber","year":"2000","unstructured":"Weber CK, Liptay S, Wirth T, et al. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology 2000; 119: 1209\u20131218.","journal-title":"Gastroenterology"},{"key":"1877_CR22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/00397919208021132","volume":"22","author":"K. Ramadas","year":"1992","unstructured":"Ramadas K, Srinivasan N. Iron-ammonium chloride\u2014A convenient and inexpensive reductant. Synth Commun1992; 22: 1389\u20131395.","journal-title":"Synth Commun"},{"key":"1877_CR23","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1021\/jm010852p","volume":"44","author":"E. Carceller","year":"2001","unstructured":"Carceller E, Salas J, Merlos M, et al.Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J Med Chem 2001; 44: 3001\u20133013.","journal-title":"J Med Chem"},{"key":"1877_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.2910170504","volume":"17","author":"C. Sundstrom","year":"1976","unstructured":"Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976; 17: 565\u2013577.","journal-title":"Int J Cancer"},{"key":"1877_CR25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","volume":"101","author":"S. Lanham","year":"2003","unstructured":"Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F, Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood 2003; 101: 1087\u20131093.","journal-title":"Blood"},{"key":"1877_CR26","doi-asserted-by":"crossref","first-page":"24359","DOI":"10.1074\/jbc.M211051200","volume":"278","author":"F. Oakley","year":"2003","unstructured":"Oakley F, Mann J, Ruddell RG, et al. Basal expression of IkappaBalpha is controlled by the mammalian transcriptional repressor RBP-J (CBF1) and its activator Notch1. J Biol Chem 2003; 278: 24359\u201324370.","journal-title":"J Biol Chem"},{"key":"1877_CR27","doi-asserted-by":"crossref","first-page":"24530","DOI":"10.1074\/jbc.M311804200","volume":"279","author":"M. Bertrand-Philippe","year":"2004","unstructured":"Bertrand-Philippe M, Ruddell RG, Arthur MJ, et al. Regulation of tissue inhibitor of metalloproteinase 1 gene transcription by RUNX1 and RUNX2. J Biol Chem2004; 279: 24530\u201324539.","journal-title":"J Biol Chem"},{"key":"1877_CR28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/sj.bjc.6690805","volume":"81","author":"M. Brimmell","year":"1999","unstructured":"Brimmell M, Burns JS, Munson P, et al. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer1999; 81: 1042\u20131051.","journal-title":"Br J Cancer"},{"key":"1877_CR29","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1128\/JVI.78.8.4108-4119.2004","volume":"78","author":"ED. Cahir-McFarland","year":"2004","unstructured":"Cahir-McFarland ED, Carter K, Rosenwald A, et al. Role of NF-kB in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J Virol 2004; 78: 4108\u20134119.","journal-title":"J Virol"},{"key":"1877_CR30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","volume":"17","author":"F. Caligaris-Cappio","year":"1999","unstructured":"Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: A bird of a different feather. J Clin Oncol 1999; 17: 399\u2013408.","journal-title":"J Clin Oncol"},{"key":"1877_CR31","unstructured":"Packham G, Stevenson FK. Bodyguards and Assassins; Bcl-2 family protein and control of apoptosis in chronic lymphocytic leukeaemia. Immunology (In press)."},{"key":"1877_CR32","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/sj.cdd.4401269","volume":"10","author":"M. Hermisson","year":"2003","unstructured":"Hermisson M, Weller M. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L\/ TRAIL-dependent death signaling pathways in human malignant glioma cells. Cell Death Differ 2003; 10: 1078\u20131089.","journal-title":"Cell Death Differ"},{"key":"1877_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00001813-200301000-00004","volume":"14","author":"PW. Gout","year":"2003","unstructured":"Gout PW, Simms CR, Robertson MC. In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs 2003; 14: 21\u201329.","journal-title":"Anticancer Drugs"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-005-1877-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-005-1877-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-005-1877-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:31:07Z","timestamp":1559154667000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-005-1877-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1007\/s10495-005-1877-0","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}